Marshall Wace
GRTX

Marshall Wace’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Marshall Wace’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-318,522
Closed -$994K – 2810
2023
Q2 		$994K Buy
318,522
+135,853
+74% +$404K ﹤0.01% 1717
2023
Q1 		$468K Buy
+182,669
New +$377K ﹤0.01% 2137
2022
Q2 		– Sell
-18,004
Closed -$43K – 3972
2022
Q1 		$43K Sell
18,004
-378
-2% -$985 ﹤0.01% 3250
2021
Q4 		$84K Sell
18,382
-64,668
-78% -$214K ﹤0.01% 3426
2021
Q3 		$673K Sell
83,050
-33,458
-29% -$287K ﹤0.01% 2244
2021
Q2 		$1.15M Buy
116,508
+62,394
+115% +$507K 0.01% 1745
2021
Q1 		$478K Buy
+54,114
New +$594K ﹤0.01% 1961

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Marshall Wace's GRTX Position: Q3 2023 in Review

Marshall Wace sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 318,522 shares — an estimated $994K sold.

Marshall Wace first reported a position in GRTX in Q1 2021 and held it in 7 quarters. The position peaked at $1.15M in Q2 2021. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

  • Marshall Wace reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 318,522 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $994K.
  • Marshall Wace first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Marshall Wace's Galera Therapeutics, Inc. Common Stock position peaked at $1.15M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.